AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Rosuvastatin in Nigeria
8 products registered with NAFDAC — 6 active, 2 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Zobitor 20 Tablet# Tablet | A4-101285 | Zobif Pharmaceuticals Limited | active | 29 Apr 2030 |
| Zobitor 10 Tablet# Tablet | A4-101284 | Zobif Pharmaceuticals Limited | active | 29 Apr 2030 |
| Robestar 10 Tablets Tablet | B4-0357 | Novartis Nigeria Limited | active | 27 Sept 2026 |
| Everdestiny Rosuvastatin Tablets 10 mg** Tablet | C4-1687 | Everdestiny Pharmaceutical Ltd | active | 6 May 2026 |
| Rosudex 20 Tablets_ Tablet | A4-6754 | Zolon Healthcare Limited | active | 24 Feb 2026 |
| Rosudex 10 Tablets_ Tablet | A4-6755 | Zolon Healthcare Limited | active | 24 Feb 2026 |
| ROZCARD 20 TABLETS | B4-8253 | ONIFAM LABORATORIES LTD. 113 | expired | 26 Feb 2023 |
| ROSUVASTA TIN TABLET TABLET | A11-0601 | ECOMED PHARM LTD PLOT 32 LYNSON CHEMICAL AVENUE | expired | 8 Feb 2023 |
Rosuvastatin — NAFDAC Registration Details
NAFDAC (Nigeria) has 8 registered products containing Rosuvastatin, of which 6 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Rosuvastatin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.